Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Income Statement [Abstract]        
Revenues
Operating Expenses        
Research and development 133,866 118,551 357,454 295,770
Research and development - related party 205,957 200,000 604,777 600,000
Selling, general and administrative 261,914 230,587 814,351 807,365
Total Operating Expenses 601,737 549,138 1,776,582 1,703,135
Loss From Operations (601,737) (549,138) (1,776,582) (1,703,135)
Other Income (Expense)        
Change in fair value of derivative liabilities 324,350 3,200 695,200 115,900
Interest expense (62,905) (9,074) (181,462) (15,830)
Amortization of debt discount (463,060) (118,425) (1,061,736) (197,925)
Total Other Expense (201,615) (124,299) (547,998) (97,855)
Net Loss $ (803,352) $ (673,437) $ (2,324,580) $ (1,800,990)
Net Loss Per Share        
- Basic and Diluted (in dollars per share) $ (0.03) $ (0.03) $ (0.09) $ (0.07)
Weighted Average Number of Common Shares Outstanding        
- Basic and Diluted (in shares) 26,066,157 25,670,917 26,066,157 25,639,208